Business Parks & Science Centres

 
 
 

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 600x60px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements from Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 5658 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 34 35 36 ... 55 56 57  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
BioNTech–MAB Discovery: antibody technology, 2013– collab mAb generation using technology of MAB Discovery 2013-01-01
Boehringer–Blackfield: cancer genomics, 2013– service application of genomics technology + computational biology for cancer drug developm 2013-01-01
Boehringer–Qiagen: molecular companion diagnostics, 2013 collab existent incl therascreen EGRF RGQ PCR Kit for Giotrif 2013-01-01
Hookipa–College Group: public relations, 201301– service Hookipa new customer of College Hill Life Sciences in early 2013 2013-01-01
Innovative Medicines Initiative–Bruker Corp: antibiotics, 201301–201712 project partner Bruker Daltonik GmbH in €29.3m TRANSLOCATION project of IMI 2013-01-01
Innovative Medicines Initiative–EU (govt): grant, 201301–201712 funding support €16m for TRANSLOCATION project by IMI total project cost €29.3m 2013-01-01
Innovative Medicines Initiative–European ScreeningPort: antibiotics, 201301–201712 partner in €29.3m TRANSLOCATION project of IMI 2013-01-01
Innovative Medicines Initiative–Ionovation: antibiotics, 201301–201712 project partner Ionovation GmbH in €29.3m TRANSLOCATION project of IMI 2013-01-01
Innovative Medicines Initiative–Jacobs Univ: antibiotics, 201301–201712 project coordinator in €29.3m TRANSLOCATION project of IMI 2013-01-01
Jacobs Univ–Bremen (govt): grant, 2013–2017 funding €15m over 5 years by Federal State of Bremen 2013-01-01
JnJ–Blackfield: cancer genomics, 2013– service application of genomics technology + computational biology for cancer drug developm 2013-01-01
Kaiser Optical Systems–Endress+Hauser: investment, 2013 acquisition by Endress+Hauser 2013-01-01
Merck (DE)–Blackfield: cancer genomics, 2013– service application of genomics technology + computational biology for cancer drug developm 2013-01-01
Omnilab (DE)–Bruker Corp: laboratory consumables, 201301– distribution of Bruker GC + MS consumables in Germany by Omnilab 2013-01-01
Panatecs–HWI Analytik: analytical services, 201301– strategic alliance offering of complementary portfolio of services 2013-01-01
Roche–Wilex: ADC technology, 2013–201508 collab ATACs with Heidelberg Pharma TERMINATED by Roche 8/15 2013-01-01
Siemens–CellaVision: cell analysis technology, 201301– distribution ww of CellaVision products by Siemens Healthcare Diagnostics 2013-01-01
Sigma-Aldrich–Olink: research reagents, 2013– distribution of Duolink reagents by Sigma-Aldrich 2013-01-01
Strüngmann Group–College Group: public relations, 201301– service AiCuris new customer of College Hill Life Sciences in early 2013 2013-01-01
SIRS-Lab–NONE: investment, 201212–201305 bankruptcy filed at Local Court Gera 8 IN 641/12 2012-12-31
Epigenomics–SEVERAL: investment, 201212–201301 capital increase just under €5m gross proceeds to avoid prospectus publication 2012-12-20
NYSE Euronext–IntercontinentalExchange: investment, 201212–201311 acquisition $11b in cash + shares 2012-12-20
Yuhan–Cevec: CAP technology, 201212– license to use CAP + CAP-T cell expression systems therapeutic protein developm + production 2012-12-20
Sartorius–Lonza: cell culture media, 201212– collab €na global sales + marketing of media + buffers by SSB which takes over Lonza medial sales team 2012-12-19
Poxel–MC Services: public relations, 201212 service existent for Poxel SA 2012-12-18
Sartorius–MKS Instruments: cheminformatics, 201212– global marketing + distribution of Umetrics’ s/w for biopharma developm + manufacturing by SSB 2012-12-18
BioNTech–4SC: TLR agonists, 201212– excl ww research + license agreem as cancer immunotherapy €2.5m + milestones + royalties 2012-12-17
Debiopharm–Roche: cancer drug, 201212– license ww excl from Chugai to develop + commercialise FF284 (Debio 1347) upfront fee + milestones + royalties 2012-12-17
JnJ–Evotec: NMDA receptor NR2B subtype selective antagonists, 201212– license excl ww compound portfolio to treat depression 2012-12-17
Intercell–Vivalis: investment, 201212–201305 merger into Valneva SE with former Vivalis owners holding 55% of shares 2012-12-16
MorphoSys–Bio-Rad: investment, 201212–201301 acquisition of AbD Serotec division for €53m in cash by Bio-Rad incl non-excl license to HuCAL 2012-12-16
Astellas–Basilea: antifungal, 201212– collab existent joint development of isavuconazole 2012-12-14
Auven Therapeutics–College Group: public relations, 201303 service existent by College Hill 2012-12-13
Cube Biotech–Creathor Venture: investment, 201212 financing round Series A led by Creathor Venture Fund III joined by local business angels 2012-12-13
Cube Biotech–SEVERAL: investment, 201212 financing round Series A led by Creathor Venture Fund III joined by local business angels 2012-12-13
Prosensa–College Group: public relations, 201212 service existent by College Hill 2012-12-13
Biocartis–SEVERAL: investment, 201212 financing round Series D €34.5m lead investor PMV using TINA fund 2012-12-12
Anagnostics–Scienion: print/spotting technology, 201211 supply use of sciFlexarrayer for production of hybcell tests incl new integrated sepsis test 2012-12-11
Biognosys–SEVERAL: investment, 201212 intermediate financing round closed 2012-12-07
Biobase–Univ Southern California: genomic s/w, 201212– distribution rights ww excl for ANNOVAR s/w from USC + CHOP 2012-12-05
PlasmidFactory–Sirion Biotech: gene delivery technology, 201212– collab pronotion of AAV vectors for preclinical ersearch 2012-12-04
Allergopharma–Merck (DE): investment, 201212 acquisition of all remaining interests by Merck who has been majority shareholder since founding 2012-12-01
Imperial College–Bruker Corp: analytical technology, 201211– Bruker is 1 of the 6 partners of newly planned MRC-NIHR Phenome Centre at Imperial 2012-11-30
Techno X–Analytik Jena: investment, 201211 acquisition of 20.05% stake in Techno X + extension of collaboration 2012-11-30
COBIK–ACIB: industrial biotechnology, 201211– collab developm of environmentally friendly processes + technologies 2012-11-28
Probiodrug–Evotec: drug development services, 201211– collab assay developm for prec-clinical + clinical developm of QC inhibitors for Alzheimer’s 2012-11-28
Roche–MIT: drug development, 201211– collab €na multi-year drug repositiong of 300 Roche compounds by Broad Institute 2012-11-28
BRAIN–SEVERAL: investment, 201211 financing round €60m led by MP Beteiligungs-GmbH + MIG Fonds 2012-11-27
Univ Bochum–DFG (DE): grant, 201211– DFG grant €7.2m for 3rd + final phase 3.5y of SFB 642 2012-11-27
Lanthio Pharma–MorphoSys: investment, 201211 financing round Series A 1st closing totalling €4.8m incl co-investor MorphoSys AG 2012-11-26
Lanthio Pharma–Several: investment, 201211 financing round Series A 1st closing €4.8m led by BioGeneration Ventures + INKEF Capital 2012-11-26
MorphoSys–Lanthio Pharma: LanthioPep technology, 201211– collab €na alliance to jointly develop LanthioPep technology 2012-11-26
Radimetrics–Bayer: investment, 201211 acquisition €na by Bayer HealthCare 2012-11-26
MVZ Dortmund–Orexo: IRIS analyser, 201211 supply existent 2012-11-23
InnoCyte–Baden-Württemberg (govt): investment, 201211 1st financing round totalling high 6-digit€ amount incl investor Seedfonds BW 2012-11-22
InnoCyte–Fraunhofer: investment, 201211 1st financing round totalling high 6-digit€ amount incl investor Fraunhofer Venture 2012-11-22
InnoCyte–High-Tech Gründerfonds: investment, 201211 1st financing round totalling high 6-digit€ amount incl investor HTGF 2012-11-22
InnoCyte–SEVERAL: investment, 201211 1st financing round high 6-digit€ amount from HTGF + Seedfonds BW + Fraunhofer Venture 2012-11-22
Evolva–Fluxome: food ingredients, 201211– acquisition of certain assets of Fluxome Sciences A/S which is in reconstruction ANNOUNCED 2012-11-21
Pronova BioPharma–BASF: investment, 201211–201301 public cash offer NOK4.996b=€684m NOK13.5/share by BASF AS 2012-11-21
Sekisui–ViruSure: quality control diagnostics, 201211– marketing of ViruSure services for virus + prion safety in Japan by Sekisui Medical 2012-11-21
BioCat GmbH–ALPCO Diagnostics: ELISA kits, 201211– distribution excl of ALPCO products in Germany by BioCat GmbH 2012-11-19
Haplogen–Evotec: virostatic agents, 201211– collab €na discovery + developm of small molecules against viral infections 2012-11-15
Tecan–Promega: lab automation equipment, 201212 collab product integration Freedom EVO – HSM workstation incl ReliaPrep gDNA Isolation System 2012-11-15
Alacris–MC Services: public relations, 201211 service existent for Alacris Theranostics GmbH 2012-11-14
GSK–Alacris: ModCell system, 201211– supply service using ModCell cancer model for drug stratification in early cancer drug discovery 2012-11-14
RJ Lee Group–Ionicon: mass spectrometer, 201211 supply existent use of PTR-MS instrument in mobile lab by RJ Lee 2012-11-13
Univ Tübingen–Germany (govt): grant, 201211– GO-Bio grant €1.7m for 2.5y for NMI project »Biomarker Tests for Drug Developom« from BMBF 2012-11-13
GeneQuine–Hamburg (govt): investment, 201211 seed financing round totalling €1m incl €500k from Innovationsstarter Hamburg 2012-11-12
GeneQuine–High-Tech Gründerfonds: investment, 201211 seed financing round totalling €1m incl €500k from HTGF 2012-11-12
GeneQuine–SEVERAL: investment, 201211 seed financing round €1m from Innovationsstarter Hamburg + HTGF 2012-11-12
Bruker Corp–Thermo Fisher: UltiMate LC system, 201211 collab co-marketing of UltiMate 3000 Standard LC with amaZon SL system by Bruker 2012-11-09
4SC–MC Services: public relations, 201211 service existent for 4SC AG 2012-11-08
Cysal–eCapital: investment, 201211 seed financing round totalling €1m incl €500k from Gründerfonds Münsterland 2012-11-08
Cysal–High-Tech Gründerfonds: investment, 201211 seed financing round totalling €1m incl €500k from HTGF II 2012-11-08
Cysal–SEVERAL: investment, 201211 seed financing round €1m from Gründerfonds Münsterland + HTGF II 2012-11-08
Lophius–Germany (govt): grant, 201211 ZIM solo grant €140k from BMWi 2012-11-08
CeGaT–Genomatix Software: molecular diagnostics, 201211 collab existent DNA sequence analysis for diagnostics 2012-11-07
Novartis–MorphoSys: HuCAL technology, 201211– collab expansion strategic alliance €na to include newly launched Ylanthia platform 2012-11-07
CCS Cell Culture Service–Cevec: CAP-T technology, 201211– license to offer CAP-T cells for cell -based assays + protein production 2012-11-05
Cypher Genomics–Biobase: genomic software tools, 201211– supply Genome Trax Knowledgebase to be used by Cypher for sequencing variant analysis 2012-11-05
Zeltia–Scienion: DNA microarrays, 201211– collab expansion product integration to provide molecular microarray solutions Genomia SAU 2012-11-05
Bruker Corp–Horiba: SPRi-MALDI platform, 201211– product integration + co-marketing of integrated SPRi-MALDI-MS system 2012-11-01
Univ Maryland–Thermo Fisher: mass spectrometer, 201211c supply Thermo LTQ Orbitrap Velos MS w ETD + NanoLC system to MS Facility at School of Pharmacy 2012-11-01
Phenex–SEVERAL: investment, 201210 financing round Series D €5m from existing investors incl EVP/RVP 2012-10-31
3D-MASSOMICS project–EU (govt): grant, 201210– FP7 grant €2.8m 2012-10-30
Tecan–Automation Partnership: automated cell culture system, 201210– collab co-promotion Freedom EVO with TAP Biosstems’ RAFT 3D cell culture system 2012-10-30
Crossing Automation–Brooks Automation: investment, 201210 acquisition $69m subject to working capital adjustment at closing 2012-10-29
EADS–Ionicon: mass spectrometer, 201210 supply existent PTR-TOF 8000 MS for several A330/A340 Airbus aircraft for air testing 2012-10-29
Menarini–Oxford BioTherapeutics: antibody cancer drug, 201210– strategic alliance to develop 5 of OBT’s AB + ADC programs 2012-10-29
Bayer–Qiagen: molecular companion diagnostics, 201210– collab developm tests for cancer drug candidates by Qiagen Manchester 2012-10-25
Cevec–SEVERAL: investment, 201210 financing round Series C €2.8m from Charité Biomedical Fund + Midas + Creathor Venture + NRW.Bank 2012-10-24
4SC–Germany (govt): grant, 201210– research grant €600k for developm personalised cancer drugs within m4 Cluster 2012-10-23
OncoMed Pharmaceuticals–Lonza: MAb contract manufacturing, 201210– supply process developm + manufacturing + GS license for MAb cancer drugs 2012-10-23
Sentinel Services (ZA)–SGS: investment, 201210 acquisition of Sentinel Services (Pty) Ltd by SGS SA 2012-10-22
Thermo Fisher–Univ Utrecht: mass spectrometry, –201210 collab advancement of Orbitrap mass analyzer using Exactive Plus MS by AJR Heck + A Makarov 2012-10-22
Protea Biosciences–Thermo Fisher: mass spectrometer, 201210 supply existent LTQ Velos MS at newly opended MSIC 2012-10-20
Dichrom–Protea Biosciences: mass spectrometry services, 201210– supply of MS services of new ProteaBio MS Center in German-speaking Europe by Dichrom 2012-10-19
Metrohm–Analytik Jena: ion chromatography, 201210 collab developm + supply new Combustion Module by Analytik Jena for Methrom’s CIC system 2012-10-19
Auxogyn–Merck (DE): prenatal diagnostics, 201210– collab Merck Serono to support development + commercialisation of Eeva Test 2012-10-18
next pagenext page 1 2 3 ... 34 35 36 ... 55 56 57  next pagenext page



Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Vienna Austria 273x168px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px

» top